State NJ
Clinical Trials in New Jersey
Recruiting clinical trials with at least one study location in New Jersey. Data updated daily from ClinicalTrials.gov.
Top Conditions in New Jersey
Frequently Asked Questions — Clinical Trials in New Jersey
How many clinical trials are currently recruiting in New Jersey?
ClinicalMetric currently tracks 258 actively recruiting clinical trials with at least one location in New Jersey. The total number of registered studies—including active but not currently enrolling trials—is 258. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Jersey?
New Jersey hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Jersey serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Jersey?
To join a clinical trial in New Jersey, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Jersey maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New Jersey
NCT06188585 N/A
Recruiting
Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal U...
Condition
Acute Gastrointestinal Bleeding
Enrollment
278 pts
Location
United States, Canada, Denmark
Sponsor
Medtronic - MITG
NCT05491213 N/A
Recruiting
TELESCOPE- TELEhealth Shared Decision-making COaching
Condition
Lung Neoplasms
Enrollment
594 pts
Location
United States
Sponsor
Rutgers, The State University
NCT05967416 Phase 1
Recruiting
Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lym...
Condition
Refractory Non-Hodgkin Lymphoma
Enrollment
24 pts
Location
United States
Sponsor
SIRPant Immunotherapeutics, In
NCT05929768 Phase 3
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple N...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
2,400 pts
Location
United States, Mexico, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT04751747 N/A
Recruiting
Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in P...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
34 pts
Location
United States
Sponsor
Rutgers, The State University
NCT04104776 Phase 1, Phase 2
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumor...
Condition
Advanced Solid Tumor
Enrollment
275 pts
Location
United States, France, Italy
Sponsor
Novartis Pharmaceuticals
NCT02704858 Phase 1, Phase 2
Recruiting
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutat...
Condition
Glioblastoma Multiforme
Enrollment
49 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
NCT06538038 N/A
Recruiting
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for ...
Condition
Non Small Cell Lung Cancer
Enrollment
538 pts
Location
United States
Sponsor
PrECOG, LLC.
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
NCT06271590 N/A
Recruiting
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in ...
Condition
Coronary Artery Disease
Enrollment
1,605 pts
Location
United States
Sponsor
Concept Medical Inc.
NCT06952660 Phase 4
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic C...
Condition
Cervical Cancer
Enrollment
100 pts
Location
United States, Puerto Rico
Sponsor
Pfizer
NCT06498960 N/A
Recruiting
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in No...
Condition
Normal Pressure Hydrocephalus
Enrollment
230 pts
Location
United States, Argentina, Canada
Sponsor
CereVasc Inc
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
NCT07266831 Phase 2, Phase 3
Recruiting
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have No...
Condition
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Enrollment
570 pts
Location
United States, Argentina, Canada
Sponsor
Merck Sharp & Dohme LLC
NCT07446439 Phase 3
Recruiting
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1...
Condition
Nausea and Vomiting
Enrollment
280 pts
Location
United States
Sponsor
Vanda Pharmaceuticals
NCT06590467 N/A
Recruiting
Abbott Structural Heart Device Registry
Condition
Heart Diseases
Enrollment
2,500 pts
Location
United States, Denmark, Estonia
Sponsor
Abbott Medical Devices
NCT03392337 N/A
Recruiting
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B ...
Condition
Psoriasis
Enrollment
30 pts
Location
United States
Sponsor
Psoriasis Treatment Center of
NCT06220201 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97...
Condition
Multiple Sclerosis
Enrollment
120 pts
Location
United States, Belgium, France
Sponsor
Juno Therapeutics, Inc., a Bri
NCT04729114 Phase 1
Recruiting
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Ca...
Condition
Prostate Cancer
Enrollment
174 pts
Location
United States, Puerto Rico
Sponsor
Astellas Pharma Global Develop
NCT05504499 N/A
Recruiting
REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low...
Condition
Lumbar Spinal Stenosis
Enrollment
100 pts
Location
United States
Sponsor
Pacific Research Institute
NCT04512716 EARLY_Phase 1
Recruiting
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Ce...
Condition
B-ALL
Enrollment
12 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06589804 Phase 3
Recruiting
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatme...
Condition
Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment
158 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06843967 Phase 1, Phase 2
Recruiting
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarco...
Condition
Well Differentiated Liposarcoma
Enrollment
54 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05064709 N/A
Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Condition
Heart Failure
Enrollment
1,500 pts
Location
United States
Sponsor
Impulse Dynamics
NCT05389293 Phase 2
Recruiting
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Ly...
Condition
Follicular Lymphoma
Enrollment
152 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
Page 1 of 11 — 258 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology